AB
HRMY icon

Amalgamated Bank’s Harmony Biosciences HRMY Stock Holding History

Amalgamated Bank’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$396K Sell
10,870
-696
-6% -$22K ﹤0.01% 1424
2026
Q1 		$324K Sell
11,566
-95
-0.8% -$3.12K ﹤0.01% 1451
2025
Q4 		$436K Buy
11,661
+333
+3% +$10.9K ﹤0.01% 1367
2025
Q3 		$312K Buy
11,328
+417
+4% +$14.4K ﹤0.01% 1451
2025
Q2 		$345K Hold
10,911
– – ﹤0.01% 1398
2025
Q1 		$362K Sell
10,911
-168
-2% -$6.02K ﹤0.01% 1361
2024
Q4 		$381K Buy
11,079
+2,074
+23% +$71.3K ﹤0.01% 1392
2024
Q3 		$360K Sell
9,005
-720
-7% -$25.3K ﹤0.01% 1421
2024
Q2 		$293K Sell
9,725
-719
-7% -$21.6K ﹤0.01% 1478
2024
Q1 		$351K Sell
10,444
-3,559
-25% -$114K ﹤0.01% 1438
2023
Q4 		$452K Sell
14,003
-1,239
-8% -$34.6K ﹤0.01% 1481
2023
Q3 		$499K Buy
15,242
+1,395
+10% +$48.4K ﹤0.01% 1411
2023
Q2 		$487K Buy
13,847
+856
+7% +$29.6K ﹤0.01% 1447
2023
Q1 		$424K Sell
12,991
-851
-6% -$38.8K ﹤0.01% 1493
2022
Q4 		$763K Buy
13,842
+30
+0.2% +$1.65K 0.01% 1258
2022
Q3 		$612K Buy
13,812
+2,234
+19% +$109K 0.01% 1336
2022
Q2 		$565K Buy
11,578
+428
+4% +$19.3K 0.01% 1409
2022
Q1 		$542K Sell
11,150
-472
-4% -$19.3K ﹤0.01% 1509
2021
Q4 		$496K Buy
+11,622
New +$463K ﹤0.01% 1577

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
CM
Capital Management Glen Allen, Virginia $666M AUM 17.17% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return

Amalgamated Bank's HRMY Position: Q2 2026 in Review

Amalgamated Bank reduced its Harmony Biosciences (HRMY) stake by 6% in Q2 2026, selling an estimated $22K and leaving 10,870 shares worth $396K. The position accounts for ﹤0.01% of the portfolio, ranked #1424.

Amalgamated Bank first reported a position in HRMY in Q4 2021 and has held it in 19 quarters since. The position peaked at $763K in Q4 2022. 130 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Amalgamated Bank held 10,870 shares of Harmony Biosciences worth $396K as of Q2 2026.
  • Amalgamated Bank sold 696 Harmony Biosciences shares in Q2 2026, an estimated $22K.
  • Harmony Biosciences made up ﹤0.01% of Amalgamated Bank's portfolio in Q2 2026, its #1424 holding.
  • Amalgamated Bank first reported a position in Harmony Biosciences in Q4 2021 and has held it in 19 quarters since.
  • Amalgamated Bank's Harmony Biosciences position peaked at $763K in Q4 2022.
  • 130 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Amalgamated Bank's 13F filing for Q2 2026, filed 23 Jul 2026.